Clinigen appoints COO for services

UK pharmaceutical supplier and service company Clinigen Group has appointed Shaun Chilton as Chief Operating Officer of its services division.

In the newly-created role. Chilton will head both Clinigen GAP, its business focused on providing global access programmes, and Clinigen CTS, its clinical trial drug supply business.

Clinigen CTS is the newly-rebranded company Keats Healthcare, which Clinigen acquired in 2010.

Chilton joins Clinigen from healthcare information supplier KnowledgePoint360 Group, where he was President and Managing Director. He previously held sales and marketing roles at Pfizer and Sanofi.

Peter George, CEO of Clinigen, commented: “Shaun has a strong track record of building and leading high-performance sales and operational teams; driving commercial growth from international businesses; developing highly effective strategies, including major restructurings; and executing new strategies to deliver business goals, improve profitability and meet challenging targets.”

“Keats Healthcare and Clinigen GAP are already successful businesses providing standalone services, but they are highly complementary and synergies between the two companies make their combination into a services division compelling,” Chilton said.